Keeping the Business Running While IT Recovers: A Practical Continuity Guide 
Helport AI Advances Transition to Autonomous AI Labor in Southeast Asian Fintech Market Guidewire to Announce Second Quarter Fiscal 2022 Financial Results on March 8, 2022
SAN MATEO, Calif.–(BUSINESS WIRE)–#EarningsDate–Guidewire (NYSE: GWRE) announced that it will release its financial results for…
Veracyte Appoints Jonathan Wygant as Chief Accounting Officer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$VCYT—Veracyte, Inc. (Nasdaq: VCYT), a global diagnostics company, today announced that…
CMCT Invests in Echo Park, Los Angeles
LOS ANGELES–(BUSINESS WIRE)–CMCT (NASDAQ: CMCT and TASE: CMCT-L) announced today that it, along with a…
Citizens Financial Group Closes Acquisition of HSBC East Coast Branches and National Online Deposit Business
HSBC branches now rebranded as Citizens PROVIDENCE, R.I.–(BUSINESS WIRE)–Citizens Financial Group, Inc. (NYSE: CFG or…
Zions Bancorporation Receives 27 Greenwich Excellence Awards For 2021
SALT LAKE CITY–(BUSINESS WIRE)–Zions Bancorporation (NASDAQ: ZION) is pleased to announce that it has received…
BrightSpire Capital, Inc. Announces Fourth Quarter & Full Year 2021 Financial Results
NEW YORK–(BUSINESS WIRE)–BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced its…
SugarCRM Launches the New SugarOutfitters Software Marketplace
SugarCRM Customers Gain Streamlined On-Demand Access to More than 200 SugarCRM Add-On Solutions for Maximum…
Radisys Introduces Engage Digital Platform for Service Providers to Monetize 4G, 5G and Fixed Network Investments in New Ways
An enhanced cloud communication platform for differentiated AI-based digital engagements and immersive communication services based…
BostonGene Earns Recognition From Cancer Cell for Its State-of-the-Art Technology in Cancer Research and Oncology
WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced its publication, “Conserved pan-cancer microenvironment subtypes predict response to immunotherapy,”…
Dine Brands Global, Inc. Announces First Quarter 2022 Dividend
Quarterly Dividend Increased by 15% The Company Authorizes Share Repurchase Program of up to $250…
Java Developer Survey Reveals Teams Not Realizing Full Promise of Microservices
10th annual survey from JRebel by Perforce finds 63% reporting an increase in microservice application…
Plus Therapeutics Partners with Medidata to Apply Innovative Synthetic Control ArmⓇ Solution to Accelerate Brain Cancer Clinical Trial
Initial plan to evaluate project feasibility, may lead to expanded partnership for clinical and regulatory implementation…
Rezolute Announces Positive Study Results for RZ402, an oral PKI being developed for DME
Phase 2 proof-of-concept study anticipated in 2H 2022 REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE…
Apellis Pharmaceuticals to Host Conference Call on February 28, 2022 to Discuss Fourth Quarter and Full Year 2021 Financial Results
WALTHAM, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Update on March 1, 2022
DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it…
Arbor Biotechnologies Appoints Steven J. Favaloro as Chief Financial Officer
Arbor Biotechnologies Appoints New CFO Steven Favaloro, CFO of Arbor Biotechnologies. CAMBRIDGE, Mass., Feb. 22,…
Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
– First New Drug Application (NDA) submission targeted in Q4 2022 for lead program SB206…
Oyster Point Pharma Announces TYRVAYA™ Nasal Spray Now Covered by Express Scripts
One of the largest pharmacy benefit management (PBM) companies in the United States has added…
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 28, 2022
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
NICE Recommends Albireo’s Bylvay® (odevixibat) for All PFIC Types
– Decision provides access to the first drug treatment approved in PFIC for patients in…